In summary, our findings suggest that one of the cancer-promoting effects of NAT10 is to promote the expression of NFE2L3, form the NAT10-NFE2L3-LASP1-Akt/GSK3β axis, and promote the occurrence and progression of ccRCC. Here, NAT10 is linked to nonpapillary renal cell carcinoma.